Ownership Summary
Cellyan Biotechnology Co., Ltd (NASDAQ:HKPD) currently has 4 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
- The collective stake of institutional investors in Cellyan Biotechnology moved to 0.8% in December 2025, a shift up from the 0.1% reported for September 2025.
- The company experienced a 507.33% quarterly change in institutional shares held, alongside an unavailable change in total owners annually.
- Among the 4 institutional holders of Cellyan Biotechnology, 3 added to their stakes while 0 trimmed their positions and 1 held steady.
- This class of investors increased its holdings in Cellyan Biotechnology to 73.59K shares for the 13F-cycle ending December 2025, up by 61.47K shares quarter on quarter, and down N/A shares year over year.
- As of December 31, 2025, StoneX Group Inc. held Cellyan Biotechnology's largest shareholding position with over 43.28K shares, representing 0.48% of total outstanding shares.
- Among the most significant buyers of Cellyan Biotechnology during December 2025 were StoneX Group Inc. (43.28K), TWO SIGMA INVESTMENTS, LP (16.75K), UBS Group AG (1.44K).
- The top 4 institutional holders of Cellyan Biotechnology for the quarter ending December 2025 included StoneX Group Inc. (43.28K), TWO SIGMA INVESTMENTS, LP (16.75K), Clear Street Group Inc. (12.02K), UBS Group AG (1.54K).